Company highlights how contact lens science and innovation meets the needs of
today’s wearers, regardless of age or correction need.
FAREHAM, England, June 2nd, 2025—At this year’s British Contact Lens Association (BCLA) Clinical Conference & Exhibition in Birmingham, Platinum sponsor CooperVision invites eye care professionals to discover how contact lenses can help people experience all of life’s beautiful moments—through every stage of life, virtually every prescription need,1 and with sustainability in mind.*2
“We believe everyone deserves to experience life’s moments with clarity and comfort,” said Marcella McParland, Senior Director of Professional Affairs, EMEA, CooperVision. “Our innovations empower eye care professionals to deliver that promise—at every stage of life.”
Throughout the conference, CooperVision will spotlight its latest clinical, scientific and sustainability initiatives, reinforcing its commitment to advancing eye care and environmental responsibility.
Meeting Virtually Every Prescription Need
With contact lens options designed to correct 99.96% of all prescriptions,1 CooperVision offers one of the most comprehensive portfolios in the industry.3 Attendees can explore:
- Sphere, toric, multifocal, and toric multifocal lenses.
- Soft lenses and orthokeratology solutions for myopia management.
- Scleral and specialty lenses for complex eye conditions.
- The company’s core soft contact lens portfolio, with over 800,000 parameters,4 spanning stock and made-to-order options.
Supporting Vision at Every Age
From childhood to presbyopia, CooperVision provides solutions for every life stage:
- MiSight® 1 day contact lenses for young people, the flagship of its evidence-based myopia management portfolio.
- A wide selection of toric and multifocal lenses for astigmats and presbyopes.3
- Ongoing clinical research and expert-led sessions on myopia control and management.
Advancing Sustainability for People and Planet*2
CooperVision continues to explore sustainable practices across its global operations. Visitors to the company’s stand can learn more about its initiatives, including:
- Sourcing Responsibly – taking steps† to conserve limited natural resources.‡5
- Recovering & Repurposing – working with partners to collect manufacturing waste, recapturing resources and giving them new life when possible.§6
- Offsetting Environmental Impact – through its Certified Plastic Neutral programme, now active in 34 countries.♢7 Thanks to its collaboration with Plastic Bank, CooperVision has helped prevent the equivalent of over 500 million plastic bottles from entering the world’s oceans.¶8
Scientific and Educational Leadership
With over 20 research papers and posters, and a range of presentations and ‘powered by’ sessions, CooperVision will share new insights across several of the most compelling topics in eye care, including myopia, astigmatism, presbyopia and sustainability. These sessions reflect the company’s ongoing investment in advancing clinical knowledge and supporting eye care professionals worldwide. Read more about the scientific content here: https://coopervision.co.uk/BCLA.
“Our presence at this year’s BCLA focuses on helping people experience life’s beautiful moments through vision. That company-wide goal inspires our research teams and partners to pursue a deeper understanding of the human eye, innovative technologies to improve sight, and novel approaches that can help the clinical community meet the needs of current and prospective patients,” said Francis Erard, Vice President of Research & Development for CooperVision.
Visit CooperVision at BCLA 2025
“As well as immersing themselves in the extensive scientific content on offer, we’re excited to welcome delegates to our stand at BCLA,” added McParland. “We invite everyone to come and enjoy a coffee, meet the CooperVision team and catch up with your peers.”
For more information, visit www.coopervision.co.uk.
###
Footnotes
* Refers to continuous manufacturing improvement processes undertaken by CooperVision to reduce its Scope 1 and 2 carbon emissions
† Refers to continuous manufacturing improvement processes undertaken by CooperVision to increase efficiency.
‡ Natural resources are defined as but not limited to water, nitrogen, natural gas and other organic compounds.
§ CooperVision's 2020 Environmental, Social and Governance Report.
♢ Plastic used in participating CooperVision soft contact lens products is determined by the weight of plastic in the blister, the lens, and the secondary package, including laminates, adhesives, and auxiliary inputs (e.g. ink). The determination does not include plastic used during the manufacturing process for both these products and their packaging.
¶ CooperVision, through its collaboration with Plastic Bank, has collected and converted approximately <10.0>M kg of plastic destined for waterways as of May 2025. Using Plastic Bank's metric of 1kg of plastic equalling 50 standard 202mm bottles, that will be the equivalent of approximately 500M plastic bottles not reaching our oceans.
References
1. CVI data on file, 2021. Rx coverage database n=101,973 aged 14 to 70 years
2. CVI data on file, 2024. US Green Building Council. Building Research Establishment
3. CVI data on File 2024. Based on prescription option combinations (sph, cyl, axis & add) available across all soft lenses in sphere, toric & multifocal, SiH and hydrogel from JJV, Alcon, B+L and CVI in UK, France, Germany and Italy Sep 2024. Includes stock & made to order lenses in daily, 2 weekly and monthy disposable options. Cosmetic & Photochromatic Cls not included. Multiple base curve variants not included
4. CVI data on File 2024. Based on prescription option combinations (sph, cyl, axis & add) available across all soft lenses in sphere, toric & multifocal, SiH and hydrogel from CVI, Sep 2024. Includes stock & made to order lenses in daily and reusable options.
5. CVI data on file, 2023.
6. CVI data on file 2023.
7. CVI data on file, 2025
8. CVI data on file as of 05/2025
About CooperVision
CooperVision, a division of CooperCompanies (Nasdaq: COO), is one of the world’s leading manufacturers of contact lenses. The company produces a full array of daily disposable, two-week and monthly soft contact lenses that feature advanced materials and optics, and premium rigid gas permeable lenses for orthokeratology and scleral designs. CooperVision has a strong heritage of addressing the toughest vision challenges such as astigmatism, presbyopia, childhood myopia, and highly irregular corneas; and offers the most complete portfolio of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com.
About CooperCompanies
CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on helping people experience life’s beautiful moments through its two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, helping to improve the way people see each day. CooperSurgical is a leading fertility and women’s healthcare company dedicated to putting time on the side of women, babies, and families at the healthcare moments that matter most. Headquartered in San Ramon, Calif., CooperCompanies has a workforce of more than 16,000, sells products in over 130 countries, and positively impacts over fifty million lives each year. For more information, please visit www.coopercos.com.
Media Contact
[LOCAL MARKET]